Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tsunehiro Yoshimura is active.

Publication


Featured researches published by Tsunehiro Yoshimura.


Asian Journal of Endoscopic Surgery | 2013

Efficacy of transanal drainage for anastomotic leakage after laparoscopic low anterior resection of the rectum.

Kae Okoshi; Yuuki Masano; Suguru Hasegawa; Koya Hida; Kenji Kawada; Akinari Nomura; Junichiro Kawamura; Satoshi Nagayama; Tsunehiro Yoshimura; Yoshiharu Sakai

Anastomotic leakage remains a devastating complication following low anterior resection of the rectum. Our aim was to retrospectively assess the efficacy of transanal drainage.


Journal of Surgical Oncology | 2016

A phase II study of neoadjuvant chemotherapy with S‐1 and cisplatin for stage III gastric cancer: KUGC03

Hiroshi Okabe; Hiroaki Hata; Shugo Ueda; Masazumi Zaima; Atsuo Tokuka; Tsunehiro Yoshimura; Shuichi Ota; Yousuke Kinjo; Kenichi Yoshimura; Yoshiharu Sakai

A multi‐center phase II study was conducted to evaluate the safety and efficacy of neoadjuvant chemotherapy (NAC) with S‐1 plus cisplatin for advanced gastric cancer.


Annals of Gastroenterology | 2017

Impact of stepwise introduction of esophagojejunostomy during laparoscopic total gastrectomy: a single-center experience in Japan

Daiki Yasukawa; Tomohide Hori; Yoshio Kadokawa; Shigeru Kato; Takafumi Machimoto; Toshiyuki Hata; Yuki Aisu; Maho Sasaki; Yusuke Kimura; Yuichi Takamatsu; Tatsuo Ito; Tsunehiro Yoshimura

Background The number of laparoscopic gastrectomies performed in Japan is increasing with the development of laparoscopic and surgical instruments. However, laparoscopic total gastrectomy is developing relatively slowly because of technical difficulties, particularly in esophagojejunostomy. Methods We retrospectively reviewed 83 patients with early gastric cancer in the upper portion of the stomach who underwent laparoscopic total gastrectomy between April 2007 and March 2016. We classified the patients into three periods, mainly on the basis of the esophagojejunostomy procedures performed: first period, various conventional procedures based on the physicians’ choice (n=14); second period, transoral method (n=51); and third period, fully intracorporeal technique (n=18). We evaluated the clinical impact of a stepwise introduction of unfamiliar new methods during laparoscopic total gastrectomy. Results Between the first and second periods, there were significant differences in the blood loss volume, number of harvested lymph nodes, frequency of conversion to open surgery, and postoperative hospital stay. The number of harvested lymph nodes was significantly higher in the third than in the second period, with no detriment to other intraoperative or postoperative factors. Conclusion The use of a unified surgical method for esophagojejunostomy seems to be the key to a successful and advantageous laparoscopic total gastrectomy. Stepwise introduction of a well-established technique of esophagojejunostomy during laparoscopic total gastrectomy will benefit patients, as shown, for example, by the higher number of dissected lymph nodes in the present study. However, a protracted learning curve is required.


Journal of Hepato-biliary-pancreatic Sciences | 2014

Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survival

Masayuki Okuno; Etsuro Hatano; Satoru Seo; Kojiro Taura; Kentaro Yasuchika; Akio Nakajima; Takefumi Yazawa; Hiroaki Furuyama; Hiroshi Kawamoto; Shintaro Yagi; Ryuta Nishitai; Takahisa Fujikawa; Akira Arimoto; Masazumi Zaima; Tsunehiro Yoshimura; Hiroaki Terajima; Satoshi Kaihara; Dai Manaka; Akira Tanaka; Shinji Uemoto

The purpose of this study was to validate the Beppu nomogram, which predicts disease‐free survival (DFS) after resection of colorectal liver metastases, and to investigate the efficacy of neoadjuvant chemotherapy based on the nomogram‐predicted recurrence risk.


World Journal of Gastroenterology | 2016

Protocol for laparoscopic cholecystectomy: Is it rocket science?

Tomohide Hori; Fumitaka Oike; Hiroaki Furuyama; Takafumi Machimoto; Yoshio Kadokawa; Toshiyuki Hata; Shigeru Kato; Daiki Yasukawa; Yuki Aisu; Maho Sasaki; Yusuke Kimura; Yuichiro Takamatsu; Masato Naito; Masaya Nakauchi; Takahiro Tanaka; Daigo Gunji; Kiyokuni Nakamura; Kiyoko Sato; Masahiro Mizuno; Taku Iida; Shintaro Yagi; Shinji Uemoto; Tsunehiro Yoshimura

Laparoscopic cholecystectomy (LC) does not require advanced techniques, and its performance has therefore rapidly spread worldwide. However, the rate of biliary injuries has not decreased. The concept of the critical view of safety (CVS) was first documented two decades ago. Unexpected injuries are principally due to misidentification of human factors. The surgeon’s assumption is a major cause of misidentification, and a high level of experience alone is not sufficient for successful LC. We herein describe tips and pitfalls of LC in detail and discuss various technical considerations. Finally, based on a review of important papers and our own experience, we summarize the following mandatory protocol for safe LC: (1) consideration that a high level of experience alone is not enough; (2) recognition of the plateau involving the common hepatic duct and hepatic hilum; (3) blunt dissection until CVS exposure; (4) Calot’s triangle clearance in the overhead view; (5) Calot’s triangle clearance in the view from underneath; (6) dissection of the posterior right side of Calot’s triangle; (7) removal of the gallbladder body; and (8) positive CVS exposure. We believe that adherence to this protocol will ensure successful and beneficial LC worldwide, even in patients with inflammatory changes and rare anatomies.


Hpb Surgery | 2016

Hepatectomy Based on Future Liver Remnant Plasma Clearance Rate of Indocyanine Green

Yuichiro Uchida; Hiroaki Furuyama; Daiki Yasukawa; Hiroto Nishino; Yasuhisa Ando; Toshiyuki Hata; Takafumi Machimoto; Tsunehiro Yoshimura

Background. Hepatectomy, an important treatment modality for liver malignancies, has high perioperative morbidity and mortality rates. Safe, comprehensive criteria for selecting patients for hepatectomy are needed. Since June 2011, we have used a cut-off value of ≧ 0.05 for future liver remnant plasma clearance rate of indocyanine green as a criterion for hepatectomy. The aim of this study was to verify the validity of this criterion. Methods. From June 2011 to December 2015, 212 hepatectomies were performed in Tenri Yorozu Hospital. Of these 212 patients, 107 who underwent preoperative computed tomography imaging volumetry, indocyanine green clearance test, and hepatectomy (excluding partial resection or enucleation) were retrospectively analyzed. Results. There was no postoperative mortality. Posthepatectomy liver failure occurred in 59 patients (55.1%) (International Study Group of Liver Surgery Grade A: 43 cases (40.2%), Grade B: 16 cases (15.0%), and Grade C: no cases). Operative morbidity greater than Clavien-Dindo Grade 3 occurred in 23 patients (21.5%). A low future liver remnant plasma clearance rate of indocyanine green was a good predictor for Grade B cases (area under curve = 0.804; 95% confidence interval, 0.712–0.895). Conclusion. Liver remnant plasma clearance rate of indocyanine green is a valid criterion for hepatectomy.


American Journal of Case Reports | 2018

Intentional Modulation of Portal Venous Pressure by Splenectomy Saves the Patient with Liver Failure and Portal Hypertension After Major Hepatectomy: Is Delayed Splenectomy an Acceptable Therapeutic Option for Secondary Portal Hypertension?

Yuichi Takamatsu; Tomohide Hori; Takafumi Machimoto; Toshiyuki Hata; Yoshio Kadokawa; Tatsuo Ito; Shigeru Kato; Daiki Yasukawa; Yuki Aisu; Yusuke Kimura; Taku Kitano; Tsunehiro Yoshimura

Patient: Female, 56 Final Diagnosis: Secondary portal hypertension Symptoms: Intractable ascites Medication: — Clinical Procedure: Splenectomy Specialty: Gastroenterology and Hepatology Objective: Unusual clinical course Background: Major or aggressively-extended hepatectomy (MAEH) may cause secondary portal hypertension (PH), and postoperative liver failure (POLF) and is often fatal. Challenges to prevent secondary PH and subsequent POLF, such as shunt creation and splenic arterial ligation, have been reported. However, these procedures have been performed simultaneously only during the initial MAEH. Case Report: A 58-year-old female with chronic hepatitis C developed a solitary hepatic cellular carcinoma with portal tumor thrombosis. Blood examination and imaging revealed a decreased platelet count and splenomegaly. Her liver viability was preserved, and collaterals did not develop, and her tumor thrombosis forced us to perform a right hepatectomy from an oncological standpoint. The estimated volume of her liver remnant was 51.8%. A large volume of ascites and pleural effusion were observed on post-operative day (POD) 3, and ascetic infection occurred on POD 14. Hepatic encephalopathy was observed on POD 16. According to the post-operative development of collaterals due to secondary PH, submucosal bleeding in the stomach occurred on POD 37. Though it is unclear whether delayed portal venous pressure (PVP) modulation after MAEH is effective, a therapeutic strategy for recovery from POLF may involve PVP modulation to resolve intractable PH. We performed a splenectomy on POD 41 to reduce PVP. The initial PVP value was 32 mm Hg, and splenectomy decreased PVP to 23 mm Hg. Thereafter, she had a complete recovery from POLF. Conclusions: Our thought-provoking case is the first successfully-treated case of secondary PH and POLF after MAEH, achieved by delayed splenectomy for PVP modulation.


World Journal of Gastroenterology | 2017

Laparoscopic appendectomy for acute appendicitis: How to discourage surgeons using inadequate therapy

Tomohide Hori; Takafumi Machimoto; Yoshio Kadokawa; Toshiyuki Hata; Tatsuo Ito; Shigeru Kato; Daiki Yasukawa; Yuki Aisu; Yusuke Kimura; Maho Sasaki; Yuichi Takamatsu; Taku Kitano; Shigeo Hisamori; Tsunehiro Yoshimura

Acute appendicitis (AA) develops in a progressive and irreversible manner, even if the clinical course of AA can be temporarily modified by intentional medications. Reliable and real-time diagnosis of AA can be made based on findings of the white blood cell count and enhanced computed tomography. Emergent laparoscopic appendectomy (LA) is considered as the first therapeutic choice for AA. Interval/delayed appendectomy at 6-12 wk after disease onset is considered as unsafe with a high recurrent rate during the waiting time. However, this technique may have some advantages for avoiding unnecessary extended resection in patients with an appendiceal mass. Non-operative management of AA may be tolerated only in children. Postoperative complications increase according to the patient’s factors, and temporal avoidance of emergent general anesthesia may be beneficial for high-risk patients. The surgeon’s skill and cooperation of the hospital are important for successful LA. Delaying appendectomy for less than 24 h from diagnosis is safe. Additionally, a semi-elective manner (i.e., LA within 24 h after onset of symptoms) may be paradoxically acceptable, according to the factors of the patient, physician, and institution. Prompt LA is mandatory for AA. Fortunately, the Japanese government uses a universal health insurance system, which covers LA.


American Journal of Case Reports | 2017

Postoperative Biliary Leak Treated with Chemical Bile Duct Ablation Using Absolute Ethanol: A Report of Two Cases

Maho Sasaki; Tomohide Hori; Hiroaki Furuyama; Takafumi Machimoto; Toshiyuki Hata; Yoshio Kadokawa; Tatsuo Ito; Shigeru Kato; Daiki Yasukawa; Yuki Aisu; Yusuke Kimura; Yuichi Takamatsu; Taku Kitano; Tsunehiro Yoshimura

Case series Patient: Female, 72 • Male, 78 Final Diagnosis: Postoperative biliary leakage Symptoms: Refractory and intractable symptoms Medication: — Clinical Procedure: Chemical ablation Specialty: Surgery Objective: Unusual setting of medical care Background: Postoperative bile duct leak following hepatobiliary and pancreatic surgery can be intractable, and the postoperative course can be prolonged. However, if the site of the leak is in the distal bile duct in the main biliary tract, the therapeutic options may be limited. Injection of absolute ethanol into the bile duct requires correct identification of the bile duct, and balloon occlusion is useful to avoid damage to the surrounding tissues, even in cases with non-communicating biliary fistula and bile leak. Case Report: Two cases of non-communicating biliary fistula and bile leak are presented; one case following pancreaticoduodenectomy (Whipple’s procedure), and one case following laparoscopic cholecystectomy. Both cases were successfully managed by chemical bile duct ablation with absolute ethanol. In the first case, the biliary leak occurred from a fistula of the right posterior biliary tract following pancreaticoduodenectomy. Cannulation of the leaking bile duct and balloon occlusion were achieved via a percutaneous route, and seven ablation sessions using absolute ethanol were required. In the second case, perforation of the bile duct branch draining hepatic segment V occurred following laparoscopic cholecystectomy. Cannulation of the bile duct and balloon occlusion were achieved via a transhepatic route, and seven ablation sessions using absolute ethanol were required. Conclusions: Chemical ablation of the bile duct using absolute ethanol is an effective treatment for biliary leak following hepatobiliary and pancreatic surgery, even in cases with non-communicating biliary fistula. Identification of the bile duct leak is required before ethanol injection to avoid damage to the surrounding tissues.


Surgical Case Reports | 2018

Portal vein aneurysm associated with arterioportal fistula after hepatic anterior segmentectomy: Thought-provoking complication after hepatectomy

Yusuke Kimura; Tomohide Hori; Takafumi Machimoto; Tatsuo Ito; Toshiyuki Hata; Yoshio Kadokawa; Shigeru Kato; Daiki Yasukawa; Yuki Aisu; Yuichi Takamatsu; Taku Kitano; Tsunehiro Yoshimura

BackgroundFew cases of postoperative arterioportal fistula (APF) have been documented. APF after hepatectomy is a very rare surgery-related complication.Case presentationA 62-year-old man was diagnosed with hepatocellular carcinoma in segments 5 and 8, respectively. Anterior segmentectomy was performed as a curative surgery. Each branch of the hepatic artery, portal vein, and biliary duct for the anterior segment was ligated together as the Glissonean bundle. The patient was discharged on postoperative day 14. Three months later, dynamic magnetic resonance imaging showed an arterioportal fistula and portal vein aneurysm. Surprisingly, the patient did not have subtle symptoms. Although a perfect angiographic evaluation could not be ensured, we performed angiography with subsequent interventional radiology to avoid sudden rupture. Arteriography was immediately performed to create a portogram via the APF from the stump of the anterior hepatic artery, and portography clearly revealed hepatofugal portal vein flow. Portography also showed that the stump of the anterior portal vein had developed a 40-mm-diameter portal vein aneurysm. Selective embolization of the anterior hepatic artery was accomplished in the whole length of the stump of the anterior hepatic artery, and abnormal blood flow through the APF was drastically reduced. The portal vein aneurysm disappeared, and portal flow was normalized. Dynamic computed tomography after embolization clearly demonstrated perfect interruption of the APF. The patient maintained good health thereafter.ConclusionsPost-hepatectomy APFs are very rare, and some appear to be cryptogenic. Our thought-provoking case may help to provide a possible explanation of the causes of post-hepatectomy APF.

Collaboration


Dive into the Tsunehiro Yoshimura's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge